Learning potential on the WCST in schizophrenia is related to the neuronal integrity of the anterior cingulate cortex as measured by proton magnetic resonance spectroscopy

BACKGROUND In recent years, schizophrenia has increasingly been recognized as a neurocognitive disorder, which has led to a growing literature on cognitive rehabilitation, and suggested several potential enhancements to cognitive function. For instance, it has been shown that executive functioning deficits as measured by the Wisconsin Card Sorting Test (WCST) can be modified in a subgroup of schizophrenic patients. The neurobiological basis of cognitive remediation has not been elucidated so far, although structural, functional and metabolic abnormalities of the prefrontal cortex have been associated with cognitive impairment. METHODS In this study, learning potential was investigated in 43 schizophrenic patients and 37 age- and education-matched healthy controls, using a dynamic version of the WCST, which integrates instructions and feedback into the testing procedure. Performance was related to cerebral metabolism, assessed by single-voxel proton magnetic resonance spectroscopy of the dorsolateral prefrontal cortex (DLPFC) and the anterior cingulate cortex (ACC). RESULTS N-acetylaspartate (NAA), a marker of neuronal integrity, was significantly reduced in the DLPFC of schizophrenic patients as compared to the healthy control group. The level of NAA in the DLPFC positively correlated with performance in the dynamic WCST in healthy subjects, whereas in schizophrenic patients a significant correlation was observed between NAA and glutamate/glutamine in the ACC and learning potential. CONCLUSION These data imply a relationship between neuronal plasticity as assessed by learning potential and NAA levels of the prefrontal cortex in schizophrenic patients and healthy subjects, and suggest the involvement of differential neuronal networks in learning for schizophrenic patients compared to healthy controls.

[1]  Zhening Liu,et al.  The relationship between regional cerebral blood flow and the Wisconsin Card Sorting Test in negative schizophrenia , 2002, Psychiatry and clinical neurosciences.

[2]  H. Matsuda,et al.  SPECT analysis of regional cerebral blood flow changes in patients with schizophrenia during the Wisconsin card sorting test , 1993, Schizophrenia Research.

[3]  S. Provencher Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.

[4]  J. Moffett,et al.  Differential distribution of N-acetylaspartylglutamate and N-acetylaspartate immunoreactivities in rat forebrain , 1995, Journal of neurocytology.

[5]  D. Glahn,et al.  Beyond hypofrontality: A quantitative meta‐analysis of functional neuroimaging studies of working memory in schizophrenia , 2005, Human brain mapping.

[6]  Joel Jeffries,et al.  Clinical Handbook of Psychotropic Drugs , 1994 .

[7]  Michael F. Green,et al.  What are the functional consequences of neurocognitive deficits in schizophrenia? , 1996, The American journal of psychiatry.

[8]  E. Vieta,et al.  Executive Function in Patients with Remitted Bipolar Disorder and Schizophrenia and Its Relationship with Functional Outcome , 2001, Psychotherapy and Psychosomatics.

[9]  L. Clare,et al.  A Meta-Analysis of Cognitive Deficits in Adults with a Diagnosis of Schizophrenia , 2005, Neuropsychology Review.

[10]  P. Maruff,et al.  Magnetic Resonance Spectroscopy and Schizophrenia: What have we Learnt? , 2000, The Australian and New Zealand journal of psychiatry.

[11]  Udo Rauchfleisch,et al.  5.4 Hamburg-Wechsler Intelligenztest für Erwachsene, Revision 1991 (Tewes, 1994) , 2001 .

[12]  Amy J. Ross,et al.  Magnetic resonance spectroscopy in cognitive research , 2004, Brain Research Reviews.

[13]  J. Coyle,et al.  The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. , 2001, The American journal of psychiatry.

[14]  Ravi S. Menon,et al.  Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS. , 2003, The American journal of psychiatry.

[15]  Ravi S. Menon,et al.  Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia , 2007, British Journal of Psychiatry.

[16]  Dennis Velakoulis,et al.  Evidence for neuronal dysfunction in the anterior cingulate of patients with schizophrenia: A proton magnetic resonance spectroscopy study at 3 T , 2007, Schizophrenia Research.

[17]  Michael F. Green,et al.  Dynamic testing in schizophrenia: does training change the construct validity of a test? , 2004, Schizophrenia bulletin.

[18]  J A Frank,et al.  Common pattern of cortical pathology in childhood-onset and adult-onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging. , 1998, The American journal of psychiatry.

[19]  S. Ganzell,et al.  Wisconsin Card Sorting Test performance in schizophrenia: remediation of a stubborn deficit. , 1992, The American journal of psychiatry.

[20]  K H Nuechterlein,et al.  Attentional characteristics of schizophrenia patients differing in learning proficiency on the Wisconsin Card Sorting Test. , 2001, Schizophrenia bulletin.

[21]  B. Everitt,et al.  The effects of neurocognitive remediation on executive processing in patients with schizophrenia. , 1999, Schizophrenia bulletin.

[22]  P. Goldman-Rakic,et al.  Cytoarchitectonic definition of prefrontal areas in the normal human cortex: II. Variability in locations of areas 9 and 46 and relationship to the Talairach Coordinate System. , 1995, Cerebral cortex.

[23]  D. Gadian,et al.  Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[24]  H. Sauer,et al.  Hypofrontality in neuroleptic-naive schizophrenic patients during the Wisconsin Card Sorting Test – a fMRI study , 2001, European Archives of Psychiatry and Clinical Neuroscience.

[25]  R W Neufeld,et al.  Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy. , 1997, Archives of general psychiatry.

[26]  S. Kay,et al.  The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.

[27]  Kevin M Koch,et al.  Dynamically shimmed multivoxel 1H magnetic resonance spectroscopy and multislice magnetic resonance spectroscopic imaging of the human brain , 2007, Magnetic resonance in medicine.

[28]  K. Mueser,et al.  Remediation of cognitive deficits in schizophrenia. , 1990, The American journal of psychiatry.

[29]  Tommaso Scarabino,et al.  Working memory deficits and levels of N-acetylaspartate in patients with schizophreniform disorder. , 2003, The American journal of psychiatry.

[30]  Martin G Pomper,et al.  In vivo differentiation of N‐acetyl aspartyl glutamate from N‐acetyl aspartate at 3 Tesla , 2007, Magnetic resonance in medicine.

[31]  Ravi S. Menon,et al.  Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers. , 2002, The American journal of psychiatry.

[32]  J. Yacubian,et al.  31P-spectroscopy of frontal lobe in schizophrenia: alterations in phospholipid and high-energy phosphate metabolism , 2002, Schizophrenia Research.

[33]  J. Bustillo,et al.  What have we learned from proton magnetic resonance spectroscopy about schizophrenia? A critical update , 2006, Current opinion in psychiatry.

[34]  Jean-Marc Constans,et al.  Proton magnetic resonance spectroscopy (1H MRS) in schizophrenia: investigation of the right and left hippocampus, thalamus, and prefrontal cortex. , 2002, Schizophrenia bulletin.

[35]  Gabriele Ende,et al.  Functioning and neuronal viability of the anterior cingulate neurons following antipsychotic treatment: MR-spectroscopic imaging in chronic schizophrenia , 2002, European Neuropsychopharmacology.

[36]  K. Berman,et al.  Meta‐analysis of neuroimaging studies of the Wisconsin Card‐Sorting task and component processes , 2005, Human brain mapping.

[37]  S. Woods,et al.  Chlorpromazine equivalent doses for the newer atypical antipsychotics. , 2003, The Journal of clinical psychiatry.

[38]  Y. Asai,et al.  Quantitative magnetic resonance spectroscopy of schizophrenia: Relationship between decreased N‐acetylaspartate and frontal lobe dysfunction , 2006, Psychiatry and clinical neurosciences.

[39]  Alessandro Bertolino,et al.  Regionally Specific Neuronal Pathology in Untreated Patients with Schizophrenia: A Proton Magnetic Resonance Spectroscopic Imaging Study , 1998, Biological Psychiatry.

[40]  C. J. Berg Glutamate and Glutamine , 1970 .

[41]  H. Sauer,et al.  Brain activation during cognitive stimulation with the Wisconsin card sorting test—A functional MRI study on healthy volunteers and schizophrenics , 1998, Schizophrenia Research.

[42]  G Tedeschi,et al.  Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. , 1996, The American journal of psychiatry.

[43]  Dennis S. Charney,et al.  Neuropsychopharmacology : The Fifth Generation of Progress , 2002 .

[44]  R. Bonelli,et al.  Cortical blood flow during rest and Wisconsin Card Sorting Test performance in schizophrenia , 2006, Wiener Medizinische Wochenschrift.

[45]  Aileen B. Sedman,et al.  A longitudinal study , 1987 .

[46]  Michael F. Green,et al.  Learning potential and the prediction of work skill acquisition in schizophrenia. , 2005, Schizophrenia bulletin.

[47]  M. Weiner,et al.  Decreased left frontal lobe N-acetylaspartate in schizophrenia. , 1997, The American journal of psychiatry.

[48]  D. Weinberger,et al.  Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. , 1986, Archives of general psychiatry.

[49]  R. Liberman,et al.  A controlled trial of cognitive remediation in schizophrenia. , 2002, Schizophrenia bulletin.

[50]  K. Wiedl,et al.  Rehab rounds: cognitive modifiability as a measure of readiness for rehabilitation. , 1999, Psychiatric services.

[51]  Jared X. Van Snellenberg,et al.  Functional neuroimaging of working memory in schizophrenia: task performance as a moderating variable. , 2006, Neuropsychology.

[52]  Jeffrey A Lieberman,et al.  Measurement of Brain Metabolites by 1H Magnetic Resonance Spectroscopy in Patients with Schizophrenia: A Systematic Review and Meta-Analysis , 2005, Neuropsychopharmacology.

[53]  Michael F. Green,et al.  48 NEUROCOGNITIVE FUNCTIONING IN PATIENTS WITH SCHIZOPHRENIA : AN OVERVIEW , 2002 .

[54]  M. Weiner,et al.  Correlation between left frontal phospholipids and Wisconsin card sort test performance in schizophrenia , 1995, Schizophrenia Research.

[55]  O. Kuss,et al.  A longitudinal study of learning potential and rehabilitation outcome in schizophrenia. , 2008, Psychiatric services.

[56]  Dieter F. Braus,et al.  Effects of age, medication, and illness duration on the N-acetyl aspartate signal of the anterior cingulate region in schizophrenia , 2000, Schizophrenia Research.

[57]  William S. Kremen,et al.  Neuropsychology in schizophrenia: an update , 2003 .

[58]  R. Heinrichs,et al.  Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. , 1998, Neuropsychology.

[59]  Gereon R. Fink,et al.  Using fMRI to decompose the neural processes underlying the Wisconsin Card Sorting Test , 2006, NeuroImage.